Filtered by:
38 Programs
-
Oncology Today with Dr Neil Love
The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer
-
-
P
-
P
-
-
P
-
P
-
-
Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer
-
-
E
-
E
-
-
E
-
E
-
-
Webinar Proceedings
Current and Future Integration of Antibody-Drug Conjugates into the Management of Metastatic Breast Cancer
-
-
A
-
A
-
A
-
-
Striving for Consensus
Clinical Investigators Review the Current and Future Role of Oral SERDs in the Care of Patients with ER-Positive Metastatic Breast Cancer
-
-
F
-
H
-
R
- +1
-
F
-